BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16225559)

  • 1. Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
    Pratoomsri W; Yatham LN; Sohn CH; Solomons K; Lam RW
    Bipolar Disord; 2005; 7 Suppl 5():37-42. PubMed ID: 16225559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
    Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
    J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
    Raja M; Azzoni A
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.
    Misdrahi D; Tournier M; Droulout T; Grolleau A; Titier K; Molimard M; Verdoux H
    Eur Psychiatry; 2008 Sep; 23(6):409-12. PubMed ID: 18755575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxcarbazepine in the treatment of affective and schizoaffective disorders].
    Dietrich DE; Kropp S; Emrich HM
    Fortschr Neurol Psychiatr; 2003 May; 71(5):255-64. PubMed ID: 12740757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine in the treatment of bipolar disorder: a review.
    Pratoomsri W; Yatham LN; Bond DJ; Lam RW; Sohn CH
    Can J Psychiatry; 2006 Jul; 51(8):540-5. PubMed ID: 16933591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine in bipolar disorder: a critical review of the literature.
    Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S
    Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.
    Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E
    Expert Rev Neurother; 2007 Jun; 7(6):617-26. PubMed ID: 17563245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder.
    MacMillan CM; Korndörfer SR; Rao S; Fleisher CA; Mezzacappa E; Gonzalez-Heydrich J
    J Psychiatr Pract; 2006 Jul; 12(4):214-22. PubMed ID: 16883146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive aripiprazole in bipolar I depression.
    Sokolski KN
    Ann Pharmacother; 2007 Jan; 41(1):35-40. PubMed ID: 17190849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine treatment of refractory bipolar disorder: a retrospective chart review.
    Ghaemi SN; Ko JY; Katzow JJ
    Bipolar Disord; 2002 Feb; 4(1):70-4. PubMed ID: 12047498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is clozapine a mood stabilizer?
    Zarate CA; Tohen M; Banov MD; Weiss MK; Cole JO
    J Clin Psychiatry; 1995 Mar; 56(3):108-12. PubMed ID: 7883728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of lamotrigine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Champion LM; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2008 Nov; 43(1):13-23. PubMed ID: 18423667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design.
    Hummel B; Walden J; Stampfer R; Dittmann S; Amann B; Sterr A; Schaefer M; Frye MA; Grunze H
    Bipolar Disord; 2002 Dec; 4(6):412-7. PubMed ID: 12519102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.